Liver Fibrosis

Overview

Journal Turk J Gastroenterol

Publisher Aves

Specialty Gastroenterology

Date 2018 Feb 3

PMID 29391303

Citations 147

Authors

M Merve Aydin

Kamil Can Akcali

Affiliations

Soon will be listed here.

Abstract

Liver fibrosis is a wound-healing response generated against an insult to the liver that causes liver injury. It has the potential to progress into cirrhosis, and if not prevented, it may lead to liver cancer and liver failure. The activation of hepatic stellate cells (HSCs) is the central event underlying liver fibrosis. In addition to HSCs, numerous studies have supported the potential contribution of bone marrow-derived cells and myofibroblasts to liver fibrosis. The liver is a heterogeneous organ; thus, molecular and cellular events that underlie liver fibrogenesis are complex. This review aims to focus on major events that occur during liver fibrogenesis. In addition, important antifibrotic therapeutic approaches and experimental liver fibrosis models will be discussed.

Citing Articles

Ferritinophagy: multifaceted roles and potential therapeutic strategies in liver diseases.

Wu K, Zhao W, Hou Z, Zhang W, Qin L, Qiu J Front Cell Dev Biol. 2025; 13:1551003.

PMID: 40070880 PMC: 11893559. DOI: 10.3389/fcell.2025.1551003.

The role of the interleukin family in liver fibrosis.

Zhang Z, Wang J, Li H, Niu Q, Tao Y, Zhao X Front Immunol. 2025; 16:1497095.

PMID: 39995661 PMC: 11847652. DOI: 10.3389/fimmu.2025.1497095.

The immunoregulatory effects of scoparone on immune-mediated inflammatory diseases.

Qiu F, Lin J, Huang X, Yang B, Lu W, Dai Z Front Immunol. 2025; 16:1518886.

PMID: 39958341 PMC: 11825328. DOI: 10.3389/fimmu.2025.1518886.

Recent advances in polymeric nanoparticles for the treatment of hepatic diseases.

Gao F, Feng X, Li X Front Pharmacol. 2025; 16:1528752.

PMID: 39925843 PMC: 11802823. DOI: 10.3389/fphar.2025.1528752.

In Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration.

Hu Y, Zhang Z, Adiham A, Li H, Gu J, Gong P Int J Mol Sci. 2025; 26(2).

PMID: 39859410 PMC: 11766297. DOI: 10.3390/ijms26020696.

References

Schuppan D, Ruehl M, Somasundaram R, Hahn E . Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis. 2001; 21(3):351-72. DOI: 10.1055/s-2001-17556. View

Iredale J . Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis. 2001; 21(3):427-36. DOI: 10.1055/s-2001-17557. View

Denda A, Kitayama W, Kishida H, Murata N, Tsutsumi M, Tsujiuchi T . Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet. Jpn J Cancer Res. 2002; 93(2):125-32. PMC: 5926952. DOI: 10.1111/j.1349-7006.2002.tb01250.x. View

Jaeschke H . Inflammation in response to hepatocellular apoptosis. Hepatology. 2002; 35(4):964-6. DOI: 10.1053/jhep.2002.0350964. View

Leclercq I, Farrell G, Schriemer R, Robertson G . Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002; 37(2):206-13. DOI: 10.1016/s0168-8278(02)00102-2. View

Iimuro Y, Nishio T, Morimoto T, Nitta T, Stefanovic B, Choi S . Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology. 2003; 124(2):445-58. DOI: 10.1053/gast.2003.50063. View

Schnabl B, Purbeck C, Choi Y, Hagedorn C, Brenner D . Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology. 2003; 37(3):653-64. DOI: 10.1053/jhep.2003.50097. View

McCaffrey A, Nakai H, Pandey K, Huang Z, Salazar F, Xu H . Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol. 2003; 21(6):639-44. DOI: 10.1038/nbt824. View

Schwabe R, Bataller R, Brenner D . Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol. 2003; 285(5):G949-58. DOI: 10.1152/ajpgi.00215.2003. View

10.

Rinella M, Green R . The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol. 2003; 40(1):47-51. DOI: 10.1016/j.jhep.2003.09.020. View

11.

Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H . Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology. 2004; 127(1):261-74. DOI: 10.1053/j.gastro.2004.04.009. View

12.

Li Z, Oben J, Yang S, Lin H, Stafford E, Soloski M . Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology. 2004; 40(2):434-41. DOI: 10.1002/hep.20320. View

13.

Low T, Leow C, Salto-Tellez M, Chung M . A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics. 2004; 4(12):3960-74. DOI: 10.1002/pmic.200400852. View

14.

Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, Perez-Carreon J, Hernandez-Garcia S, Salcido-Neyoy M . Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett. 2004; 217(1):25-32. DOI: 10.1016/j.canlet.2004.07.019. View

15.

Bataller R, Brenner D . Liver fibrosis. J Clin Invest. 2005; 115(2):209-18. PMC: 546435. DOI: 10.1172/JCI24282. View

16.

Friedman S . Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol. 2005; 1(2):98-105. DOI: 10.1038/ncpgasthep0055. View

17.

Breitkopf K, Godoy P, Ciuclan L, Singer M, Dooley S . TGF-beta/Smad signaling in the injured liver. Z Gastroenterol. 2006; 44(1):57-66. DOI: 10.1055/s-2005-858989. View

18.

Anstee Q, Goldin R . Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006; 87(1):1-16. PMC: 2517349. DOI: 10.1111/j.0959-9673.2006.00465.x. View

19.

Zhan S, Jiang J, Wu J, Halsted C, Friedman S, Zern M . Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology. 2006; 43(3):435-43. DOI: 10.1002/hep.21093. View

20.

Brown B, Lindberg K, Reing J, Stolz D, Badylak S . The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng. 2006; 12(3):519-26. DOI: 10.1089/ten.2006.12.519. View